Vivimed Labs logo

Vivimed Labs results

NSE: VIVIMEDLABBSE: 532660Pharmaceuticals & BiotechnologySmall Cap

Last close ₹6.09down ₹0.12 (1.93%)BSE ₹6.11

Share price at the NSE close on 23 Oct 2026. Previous close ₹6.21.

Market cap
₹50 Cr3,293rd largest listed
P/E
No recent results
P/B
No recent results
Dividend yield
Nonein the last 12 months
Volume, NSE
75

Q4 results, quarter to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Vivimed Labs annual results and balance sheet

Revenue
₹12 Cr−53.2% on a year ago · −24.9% on the quarter before
Operating profit
−₹139 Cr
Net profit
−₹146 Cr
Earnings per share
−₹17.74
Operating margin
−1,159.9%
Net margin
−1,217.0%

From revenue to net profit, ₹ crore

  1. Revenue12
  2. Materials and goods−47
  3. Employee costs−10.0
  4. Other expenses−94
  5. Operating profit−139
  6. Depreciation−12
  7. Other income+5.7
  8. Finance costs−0.9
  9. Profit before tax−146
  10. Tax−0.1
  11. Net profit−146

Vivimed Labs results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Mar 2026. Results for the quarter to Jun 2026 were due by 14 Aug 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreJun 2021Q1Filed 17 AugSep 2021Q2Filed 18 NovDec 2021Q3Filed 16 FebMar 2022Q4Filed 17 JunJun 2022Q1Filed 6 SepSep 2022Q2Filed 25 NovDec 2022Q3Filed 16 FebMar 2023Q4Filed 11 JulJun 2023Q1Filed 30 NovSep 2023Q2Filed 30 NovDec 2023Q3Filed 27 FebMar 2024Q4Filed 15 NovJun 2024Q1Filed 18 JanSep 2024Q2Filed 17 JanDec 2024Q3Filed 15 FebMar 2025Q4Filed 21 JulJun 2025Q1Filed 14 AugSep 2025Q2Filed 14 NovDec 2025Q3Filed 13 MarMar 2026Q4Filed 17 Jul
Revenue from operations6554576150445637353441392925372621211612
546564625954612013640406740253528222227151
Materials and goods bought354041382824381821818221417112011109847
Employee costs999107899810107667966410
Other expenses1117131524221310101294617887671594
Operating profit before depreciation11−10−7−1−9−9−5−1640−61−28−11−11−20−1−11−139
Operating margin16.5%−19.3%−12.9%−1.8%−17.1%−21.0%−9.2%−443.7%−0.9%−17.5%3.1%−73.7%−37.4%−2.6%2.9%−7.8%−1.3%−4.6%−68.3%−1,159.9%
Depreciation and amortisation5445444965556447655512
Other income10010001020800040006
Finance costs10912109999111213−3300021211
One-off items00000000000000000000
Profit before tax−2−23−24−16−22−22−18−268−16−20−177−15−5−6−5−5−7−17−146
0003000−2−10−1100000000
Tax rate–––––––––––20.9%––––––––
−2−23−24−18−22−22−18−266−14−20−165−15−5−6−5−5−7−17−146
Other comprehensive income00000001000100000000
Total comprehensive income−2−23−24−18−22−22−18−265−14−20−166−15−5−6−5−5−7−17−146
Net margin−3.6%−42.8%−41.9%−30.0%−44.3%−49.8%−32.9%−718.3%−40.6%−60.3%−38.7%13.6%−51.9%−20.8%−16.4%−20.1%−25.7%−35.4%−103.5%−1,217.0%
Earnings per share––––––––––––––––––−₹0.88−₹17.74
Diluted earnings per share––––––––––––––––––−₹0.85−₹17.22
Earnings per share in rupees, restated for later splits and bonuses.

The quarter to Jun 2023 was restated in the company's filing of 30 Nov 2023. The table shows the restated figures.

Filed results, as an XML file each

16 earlier filings